Since 2000, the annual Work Plan of the Office of the Inspector General (OIG) listed clinical research and clinical trials as a compliance target. As a result, sponsors, investigators, and institutions have increased their vigilance over the operation of clinical research activities. Have those efforts been in the right direction? Have they been enough?
This session will focus on learning the perspective, understanding the actions, and preparing to respond to the OIG’s position and priorities.
Presenters
- William Moran is the recently retired regional inspector general for the U.S. Department of Health & Human Services, Region V. Mr. Moran currently is a vice president with the Chicago office of Strategic Management Systems, Inc.
- LaDale K. George is a partner with Foley’s Health Care Industry Team and is the leader of the Translational Research Focus Group.
Related Insights
14 March 2025
Manufacturing Industry Advisor
Brainwaves: 100 Days and Beyond | Presidential Policy Shifts Impacting Automotive
In a recent Brainwaves event hosted by the Society of Automotive Analysts and Foley & Lardner LLP, titled “100 Days and Beyond: Presidential Policy Shifts Impacting Automotive,” business and legal executives gathered in Detroit to discuss the significant shifts in presidential policies and their profound impact on the automotive sector.
23 April 2025
Events
Rooftop Reception at IAPP Global Privacy Summit 2025
Following the first day of the International Association of Privacy Professionals’ 2025 Global Privacy Summit, Foley & Lardner’s Cybersecurity & Data Privacy team will be hosting a networking reception on the rooftop of The Delegate, conveniently located across the street from the venue.
13 March 2025
Foley Ignite
New Opportunities and Challenges for Board Directors
Foley & Lardner LLP recently co-hosted a webinar with the National Association of Corporate Directors to discuss how a new presidential administration and evolving state-driven regulations are effecting boardrooms.